
A mental health smartphone app developed by a team of Northwestern Medicine investigators helped improve depressive symptoms in patients with diabetes and hypertension, according to a recent clinical trial published in JAMA.

A new wearable device developed at Northwestern measures mothers’ and babies’ vital signs and data that cannot be collected with current technology.

A new wearable sensor that actually quantifies itch by measuring scratching when placed on the hand has been developed by Northwestern University scientists.

An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial.

Gender-affirming hormone treatment caused cholesterol levels to increase for people designated male at birth and decrease for people designated female at birth, according to a recent study.

Lakeside Discovery, LLC, the collaboration between Northwestern University and Deerfield Management, will support the laboratory of Paul DeCaen, PhD in a multi-year partnership to advance new therapies for genetically driven polycystic kidney disease.

A massive trove of information produced in a Northwestern-led study will lay the groundwork for understanding sex-related differences in health and disease for decades to come.

A Northwestern Medicine study has shown that a high-intensity home-based walking exercise program improved walking ability in people with peripheral artery disease.

Developed by Northwestern scientists, a novel skin-mounted sticker that absorbs sweat and then changes color can provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.

The largest study to date of neurological manifestations of COVID-19 in children demonstrated patterns in the rare complications seen among pediatric patients.